I

Ionis Pharmaceuticals, Inc.

853 employees

Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.

Investor insights

Sectors invested in

Biotechnology4
Health Care2
Pharmaceutical2
Medical2
Therapeutics2
Protein Therapeutics1
Life Science1
Artificial Intelligence1
Machine Learning1
siRNA1
Drug Delivery1
Protein Engineering1
Drug Development1
Immunology1
Genetic Medicine1
Bispecifics1
Oligonucleotide Delivery1
Tissue-specific Targeting1
Drug Discovery1
Protein Conjugation1

Funding rounds participated in

$49M sweet spot round size

Most of their 4 investments are in rounds between $6.8M and $80M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
RNA-Targeted Therapeutics
Medical
Pharmaceutical
Antisense Drug Discovery

Date founded

1989

Investments made

M

Metagenomi raised $80M on November 14, 2022

Investors: Ionis Pharmaceuticals, Inc.

A

Aro Biotherapeutics raised $88M on January 5, 2021

Investors: BioMotiv, Ridgeback Capital Management LLC, HealthCap, Northpond Ventures and Ionis Pharmaceuticals, Inc.

E

Empirico Inc. raised $17M on January 9, 2020

Investors: Neotribe Ventures, DCVC Bio and Ionis Pharmaceuticals, Inc.

A

Atlantic Healthcare plc raised $6.8M on March 1, 2007

Investors: Ionis Pharmaceuticals, Inc.

FAQ